澳大利亚即将推出Wegovy片剂,与减肥注射剂相比如何?
Australia is set to get a Wegovy pill. How does it compare with weight‑loss injections?
澳大利亚TGA批准了Wegovy片剂,四种不同剂量可供选择。片剂每日空腹服用,需等待30分钟后再进食或饮水。与注射剂相比,片剂使用更方便,但需每日服用且注意饮食。常见副作用包括恶心、呕吐等,严重副作用包括肾损伤等。Wegovy片剂尚未纳入PBS,患者需自费购买。
原文详细介绍了Wegovy片剂在澳大利亚的上市情况及其与注射剂的比较,有助于读者了解新药的优势与风险。
A new tablet version of Wegovy, a peptide used to help people lose weight, has been approved for the first time in Australia.
Until now, the best-known medicines in this group (semaglutide, sold as Wegovy or Ozempic, and tirzepatide, sold as Mounjaro) have generally required weekly injections. The new daily tablet offers another option for people who would prefer not to (or can't) inject themselves.
But how does it work? And will swallowing a pill make weight loss easier, cheaper or safer?
What are Wegovy pills, and what's changed?
Wegovy contains semaglutide, a medicine that copies the action of a naturally occurring hormone called glucagon-like peptide-1 (GLP-1). This hormone helps regulate blood sugar, appetite and digestion.
On Tuesday, Australia's Therapeutic Goods Administration (TGA) registered four strengths of Wegovy tablets: 1.5mg, 4mg, 9mg and 25mg.
This makes it the first GLP-1 medicine approved in Australia in tablet form specifically for weight management.
How do the tablets work, and who are they for?
Semaglutide acts on the brain and digestive system. It reduces hunger, increases feelings of fullness and slows how quickly food leaves the stomach. This can help people feel satisfied with smaller meals and reduce how often they feel hungry.
The medicine is intended for adults living with obesity, or people who are overweight and have other weight-related health conditions. It may also be prescribed to some people with heart (cardiovascular) disease to reduce their risk of serious heart problems, such as heart attack or stroke.
These medicines are not intended as a quick fix for people wanting to lose a few kilograms. They are prescription treatments that should be considered as part of a person's broader health needs, with guidance from a health care professional.
How do the pills compare to injections?
The Wegovy tablet must be taken daily, on an empty stomach with a small amount of water, with a 30-minute wait before you eat or drink anything other than water. It contains a special absorption aid to allow the medicine to pass through stomach acid, be absorbed properly and work effectively.
In contrast, the injection can be done any time of day, once weekly, with or without food.
Both formats make you feel fuller faster, and trials showed similar gastrointestinal effects, especially when first starting.
Overall, they show similar rates of weight loss, with the tablet showing a 14% body weight loss over 64–68 weeks, and the injection showing a 15% weight reduction. However, the pill's effectiveness relies on people remembering to take it each day and not eat or drink within half an hour of the dose, rather than just remembering to inject the drug once a week.
What are the risks?
Common side effects—affecting around 80% of patients—include nausea, vomiting, diarrhea, indigestion and constipation.
Less common but more serious side effects include kidney injury, pancreatitis and gallbladder problems.
Higher doses make negative side effects more severe. With a tablet, it's important for people to know that, just as for an injection, doubling up their dose won't encourage faster results and could cause harm.
Doctor appointments are short, meaning they sometimes lack proper screening for eating disorders, body image or other psychological issues. Previous research has also highlighted a link between suicidal thoughts and GLP-1 use. So unless these issues are discussed in appointments, it could lead to negative outcomes for patients.
An oral tablet may be easier for people who don't like needles or have trouble using them, and could reduce potential injection-related injuries. Recently, needle and syringe programs have been overwhelmed with demand for needles used for GLP-1s and other peptides.
When will pills be available, and what will they cost?
The TGA approval doesn't mean you can walk into your doctor's office and get a prescription today.
Before Wegovy tablets hit the shelves, the TGA will complete a final review of packaging and production, as well as retail pricing. Novo Nordisk, the company that manufactures Wegovy, aims to have tablets available in Australia by the end of the year.
It is also important to distinguish TGA approval from Pharmaceutical Benefits Scheme (PBS) listing. TGA approval means a medicine can be prescribed for its approved uses. PBS listing means the government subsidizes its cost. Wegovy is not currently subsidized through the PBS for weight management, meaning patients should expect to pay the full price.
Official pricing hasn't been released yet. However, the weekly injection costs A$250–$450 a month and the pill's out-of-pocket costs are likely to be similar.
Is this a 'magic pill?'
This pill isn't meant to be used by itself. The TGA has approved Wegovy tablets to use alongside a reduced-calorie diet and increased physical activity.
It's also important to follow prescriber guidelines, eat nutritious food and do weight training to help avoid muscle loss.
This is why "lifestyle prescribing" should accompany any weight-loss drugs, which means GPs should also make a clear plan with patients to encourage healthy eating and regular exercise, alongside weight-loss medications.
This matters because when people lose weight quickly, some of what they lose is lean muscle, not just body fat.
Secondly, the weight can come back if you stop taking Wegovy without having changed your lifestyle. Follow-up research with participants has found people regained about two-thirds of the weight they had lost within a year of stopping these medications.
Who's behind this story?
Lisa Lock
BA art history, MA material culture. Former museum editor, paramedic, and transplant coordinator. Editing for Science X since 2021. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
This article is republished from The Conversation under a Creative Commons license. Read the original article.
Citation: Australia is set to get a Wegovy pill. How does it compare with weight‑loss injections? (2026, November 4) retrieved 4 November 2026 from https://medicalxpress.com/news/2026-11-australia-wegovy-pill-weightloss.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com